Silvercrest Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.13M Sell
6,481
-29,976
-82% -$7.95M 0.02% 496
2026
Q1
$4M Buy
36,457
+5,379
+17% +$766K 0.03% 455
2025
Q4
$5.17M Buy
31,078
+11,906
+62% +$1.99M 0.04% 428
2025
Q3
$3.75M Sell
19,172
-11,922
-38% -$1.96M 0.02% 464
2025
Q2
$2.81M Sell
31,094
-1,031
-3% -$81.5K 0.02% 505
2025
Q1
$1.92M Sell
32,125
-760
-2% -$70.3K 0.01% 548
2024
Q4
$4.36M Sell
32,885
-564
-2% -$52.9K 0.03% 440
2024
Q3
$1.75M Buy
+33,449
New +$1.57M 0.01% 511

Other funds holding ALAB

Silvercrest Asset Management's ALAB Position: Q2 2026 in Review

Silvercrest Asset Management reduced its Astera Labs (ALAB) stake by 82% in Q2 2026, selling an estimated $7.95M and leaving 6,481 shares worth $3.13M. The position accounts for 0.02% of the portfolio, ranked #496.

Silvercrest Asset Management first reported a position in ALAB in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.17M in Q4 2025. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Silvercrest Asset Management held 6,481 shares of Astera Labs worth $3.13M as of Q2 2026.
  • Silvercrest Asset Management sold 29,976 Astera Labs shares in Q2 2026, an estimated $7.95M.
  • Astera Labs made up 0.02% of Silvercrest Asset Management's portfolio in Q2 2026, its #496 holding.
  • Silvercrest Asset Management first reported a position in Astera Labs in Q3 2024 and has held it in 8 quarters since.
  • Silvercrest Asset Management's Astera Labs position peaked at $5.17M in Q4 2025.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.